FY2025 Earnings Estimate for IKT Issued By Lifesci Capital
Inhibikase Therapeutics, Inc. (NYSE:IKT - Free Report) - Lifesci Capital issued their FY2025 EPS estimates for Inhibikase Therapeutics in a report issued on Monday, December 1st. Lifesci Capital...